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Introduction
Acute kidney injury (AKI) is a well-known and serious
complication following cardiopulmonary bypass
(CPB), occurring in as many as 11–17% of infants and
children following repair of congenital heart defects
(CHD) (1,2). Several factors including young age (3,4),
small size (3), complexity of the heart defect (4), and
CPB duration (5,6) have previously been identified as
risk factors for renal dysfunction in children. However,
varying definitions of renal insufficiency, small and/or
homogeneous samples, and limited sets of perioperative
factors investigated leave a significant gap in our current
understanding of this phenomenon. Additionally, several
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Summary
Acute kidney injury (AKI) is a serious complication that occurs commonly
following cardiopulmonary bypass (CPB) in infants and children. Underly-
ing risk factors for AKI remain unclear, given changes in CPB practices
during recent years. This retrospective, case–control study examined the
relationships between patient, perioperative factors, AKI, and kidney
failure in children who underwent CPB.
Methods: Cohorts of children with and without AKI were identified from
the cardiac perfusion and nephrology consult databases. Demographic,
perioperative, and postoperative outcome data were extracted from the
databases and from medical records. Children were stratified into groups
based on the Acute Dialysis Quality Initiative’s RIFLE definitions for
acute kidney risk or injury (AKI-RI) and kidney failure.
Results: The study groups included 308 controls (no AKI-RI or failure),
161 with AKI-RI, and 89 with failure. Young age, preoperative need for
mechanical ventilation, milrinone, or gentamicin; intraoperative use of mil-
rinone and furosemide; durations of CPB and anesthesia; multiple cross-
clamp and transfusion of blood products were significantly associated with
AKI or failure. Young age, perioperative use of milrinone, multiple cross-
clamps, extracorporeal membrane oxygenation, cardiac failure, neurologi-
cal complications, sepsis, and failure significantly increased the odds of
mortality.
Conclusion: This study identified multiple perioperative risk factors for
AKI-RI, failure, and mortality in children undergoing CPB. In addition to
commonly known risk factors, perioperative use of milrinone, particularly
in young infants, and furosemide were independently predictive of poor
renal outcomes in this sample. Findings suggest a need for the development
of protocols aimed at renal protection in specific at risk patients.
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significant changes in CPB practices have occurred
over the past decade, including changes in pump tech-
nology, pump prime solutions, use of hemofiltration
and modified ultrafiltration (MUF), as well as use of
agents such as aprotinin and newer vasoactive sub-
stances. While such techniques have resulted in
improved hemostasis, hemodynamics, and inflamma-
tory responses during CPB, the impact of such practice
changes on the risk for AKI remains unclear. Given
the known association between AKI and increased
morbidity and mortality in adults and children, parti-
cularly in those requiring dialysis (7–10), a greater
understanding of associated risk factors may facilitate
studies that evaluate interventions targeted at protec-
tion of renal function during and following CPB.
The purpose of this retrospective, case–control study
was therefore to examine the relationships between
multiple perioperative factors, AKI and failure or the
need for dialysis in children who underwent CPB and
to identify underlying conditions that, if targeted for
intervention, may minimize the risk for AKI.
Methods
This retrospective study was approved by the Univer-
sity of Michigan Institutional Review Board with a
waiver of informed consent. A nested case–control
study design was used to identify the sample taken
from all children (birth to <18 years) who underwent
CPB for repair of a CHD between 1998 and 2006. A
cohort of children was identified from the nephrology
consult list over this study period to generate a large
sample of children with potential adverse renal out-
comes. The control group was identified using a proba-
bility sample (i.e., computer-generated, random
selection), twice the size of the consultation list,
obtained from the cardiac perfusion database over the
same period. All duplicate patients (i.e., children who
underwent bypass more than once) were excluded, as
were children who had chronic renal failure preopera-
tively or who underwent cardiac transplantation.
Standardized institutional guidelines for pediatric
CPB circuit components, pump flows, and cardioplegia
were adhered to throughout this study period. Stan-
dard anticoagulation was carried out with heparin
400–500 units per kg. A kaolin-ACT (Hemochron Jr.)
was utilized, and an ACT of >450 s was obtained
before initiation of CPB. Packed red blood cells
(PRBCs) were added to the CPB priming solution if
the calculated hematocrit (Hct) was <27% (goal of no
<25%). Mannitol (0.25 GÆkg)1) was added to all
priming solution and given again during re-warming.
Steroids were given to all children who underwent
circulatory arrest. Nonpulsatile CPB was employed
using a roller pump and a microporous hollow fiber
membrane oxygenator. Pump flows were weight based
and adjusted according to surgeon specifications. Mean
arterial pressure during bypass was maintained at 20–
50 mmHg depending on the age of the patient except
during surgical request for low flow states. Conven-
tional ultrafiltration was used during the re-warming
phase of CPB as needed (to increase hematocrit and
remove excess volume in the venous reservoir.) Modi-
fied ultrafiltration was conducted for 10 min immedi-
ately postbypass for all children <15 kg. Use of deep
hypothermic circulatory arrest (DHCA) was based on
the complexity of the surgical procedure as well as
patient weight. Anesthetic care including fluid manage-
ment, use of inotropes, diuretics, and transfusions, was
based on individual patient needs. In general, dopa-
mine was administered to facilitate weaning from CPB.
Epinephrine was used to provide inotropic support for
neonates and as needed in others. Milrinone was
added as needed to reduce afterload, and lastly, vaso-
pressin was added to improve systemic vascular tone.
Electronic and paper medical records, including the
preoperative anesthesiology and cardiology medical
history and physical examinations, intraoperative
anesthesia and perfusion flowsheets, postoperative
intensive care unit (ICU) flowsheets, progress and dis-
charge notes, were reviewed for data retrieval.
Research assistants blinded to the purpose of the
study recorded all data that included: demographics,
surgical procedure coded in accordance with the Risk
Assessment in Congenital Heart Surgery criteria
(RACHS-1) (11), baseline and postoperative labora-
tory values for the first 3 postoperative days (PODs)
(e.g. serum creatinine [SCr] and blood urea nitrogen),
CPB and circulatory arrest data, intraoperative times
(total anesthetic duration, DHCA time and cross-
clamp time) medications (including inotropes, diuret-
ics, gentamicin, aprotinin, etc.), urine output over the
first 3 days, and postoperative course (including all
complications and mortality).
The outcomes for this study included acute renal
failure risk or injury (AKI-RI), kidney failure and
death. Postoperative AKI-RI was classified using the
Acute Dialysis Quality Initiative’s ‘RIFLE’ criteria
(12), recently modified for children (pRIFLE) (13) as:
1.5–2 times increase in SCr from baseline, and/or urine
output <0.5 mlÆkg)1 per h over any 24-h period during
the first 3 PODs. Children who required dialysis (peri-
toneal or hemodialysis) at any time during their post-
operative course were identified with failure.
Additional pre- and postoperative conditions, includ-
ing cardiac failure, neurological complications and
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sepsis, were derived from inpatient cardiology and sub-
specialty notes and discharge summaries.
Statistical analysis was conducted using SPSS software
(SPSS Inc., Chicago, IL, USA). Data are presented as
n (%) or mean ± standard deviation, as appropriate.
Univariate analyses (Student t tests or chi square with
Fisher’s exact tests, as appropriate) were conducted to
evaluate the associations between patient, perioperative
factors, and renal outcomes groups (AKI-RI or failure
vs other children). Significant relationships are pre-
sented using odds ratios (OR) and confidence intervals
(CI). Several logistic regression models (backward,
stepwise) were developed to examine the relationships
between preoperative, intraoperative and pertinent
postoperative outcomes and the renal outcomes
groups. P values < 0.05, corrected as appropriate
for unequal variance, were accepted as statistically
significant.
Results
One hundred sixty-six of 238 children in the nephrol-
ogy consult database met study inclusion criteria.
Three hundred and twenty-eight children were selected
from the balance of 4611 in the perfusion database.
The records of the combined groups (n = 494) were
reviewed. Eight children who died intraoperatively or
in the immediate postoperative period (within hours)
were excluded from this study, as they had no labora-
tory values and could not be classified into one of the
renal outcomes groups. Following careful review of the
records, the final sample was stratified as follows: 308
controls (no AKI-RI or failure), 161 who had AKI-RI
during the first 3 POD, and 89 who developed kidney
failure during their hospitalization. Characteristics of
these samples and the relationships between periopera-
tive factors are described in Table 1. Stepwise, back-
ward logistic regression models were generated to
examine factors that were independently associated
with the outcomes. The first model regressed the fol-
lowing independent factors on AKI-RI: age, preopera-
tive diuretics, nephrotoxic antibiotics, mechanical
ventilation, and milrinone; intraoperative minutes,
CPB minutes; multiple cross-clamps; MUF, ultrafil-
trate; milrinone, epinephrine, and transfusion. The sec-
ond included the following factors regressed on kidney
failure: age, preoperative diuretics, nephrotoxic anti-
biotics, mechanical ventilation, milrinone and dobuta-
mine; intraoperative minutes, CPB minutes, multiple
cross-clamps, ultrafiltrate; milrinone, epinephrine, and
transfusion (Table 2). A third model added an interac-
tion factor between dobutamine and age, as this agent
is used more often in younger infants in this setting.
This additional factor did not alter findings related to
the independent associations for AKI-RI or failure.
Of the children who required dialysis, 27 (30%) had
peritoneal dialysis, 43 (48%) were placed on continu-
ous veno-venous hemofiltration (CVVH) or hemodialy-
sis, and 19 (21%) had peritoneal and hemodialysis.
There were no differences in age or RACHS-1 score
between children with peritoneal vs other dialysis
methods. However, hemodialysis was initiated signifi-
cantly earlier postoperatively compared to peritoneal
dialysis (5.3 ± 8.7 vs 9.3 ± 14.8 days; P = 0.47). The
time to initiation of dialysis ranged from 0 to
61 days after surgery (6 ± 10.6 days), and duration of
dialysis in survivors ranged from 1 to 79 days
(12.8 ± 18.5 days).
Table 3 displays the relationships between other per-
tinent postoperative outcomes and renal outcomes.
AKI-RI and failure were significantly associated with
respiratory, neurologic, cardiovascular, infectious com-
plications, and mortality postoperatively (P < 0.017).
A significantly greater proportion of children who
underwent peritoneal dialysis survived compared to
those who required CVVH or hemodialysis (48.1% vs
12.9%, respectively). Factors that were associated with
death by univariate analysis were entered into a logis-
tic regression model with backward selection. The fol-
lowing factors were found to be independently
associated with mortality: young age (Wald 6.3;
Exp(B) 1.3 [CI 1–1.6]; P = 0.012), preoperative use of
milrinone (4.6; 5.7 [1.2–28]; 0.032), intraoperative use
of milrinone (8.6; 4.4 [1.6–11.9]; 0.003), multiple cross-
clamps (8.2; 9.1 [2–40.8]; 0.004), extracorporeal mem-
brane oxygenation (ECMO) (21.2; 17 [5.1–56.8];
<0.001), cardiac failure (12.9; 5.9 [2.2–15.4]; <0.001),
neurological complications (4.5; 3.6 [1.1–11.7]; 0.03)
sepsis (11.6; 6 [2.1–16.9]; 0.07), and kidney failure
(24.6; 12.8 [4.7–35.1]; <0.001).
Discussion
This retrospective, cohort study identified multiple pre-
operative and intraoperative factors associated with
renal failure in children undergoing CPB. While several
of these factors have been well documented, several
previously unreported risk factors have been identified.
Perioperative use of certain inotropic agents, diuretics,
and gentamicin were found to be independently associ-
ated with poor renal outcomes in this setting. Addi-
tionally, similar to recent studies in children (14,15),
use of aprotinin was not associated with poor out-
comes in this sample. These findings identify children
at risk for renal failure, which, in turn, may guide
future research aimed at reducing risk.
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Age (years) 3.55 ± 5.5 1.45 ± 3.6b 1 ± 2.6b
Neonate (£1 month) 156 (51%) 93 (58%) 50 (56%)
Weight (kg) 15.2 ± 20 8.1 ± 12.9b 6.7 ± 9.6b
Male gender 185 (60%) 89 (55%) 52 (58%)
Baseline creatinine 0.64 ± 0.27 0.55 ± 0.23 0.68 ± 0.65
Baseline blood urea nitrogen 14 ± 9.2 14.6 ± 11.58 18.2 ± 16.1
Baseline hematocrit 41.0 ± 6.2 42.0 ± 6.2 42.3 ± 6.0
Diuretics 150 (49%) 96 (60%) [1.54;1, 2.3]b 58 (65%) [1.9; 1.2, 3.1]b
Gentamicin/vancomycin 43 (14%) 39 (24%) [1.8; 1.1, 3]b 30 (34%) [3; 1.8, 5.1]b
Mechanical ventilation 91 (30%) 75 (47%) [2; 1.3, 2.9]b 45 (51%) [2.1; 1.3, 3.4]b
Inotropic support 76 (25%) 54 (34%) 34 (38%) [1.8; 1.1, 2.9]b
Dopamine 68 (22%) 43 (27%) 26 (29%)
Milrinone 8 (3%) 14 (9%) [3.8; 1.5, 9.2]b 9 (10%) [3.3; 1.4, 8]b
Epinephrine 10 (3%) 6 (4%) 5 (6%)
Vasopressin 1 (<1%) 2 (1%) 1 (1%)
Dobutamine 14 (5%) 11 (7%) 10 (11%) [2.8; 1.2, 6.4]b
ECMO 2 (1%) 4 (3%) 6 (7%) [9.5; 2.3, 38.7]b
Previous cardiac surgery 90 (29%) 42 (26%) 28 (32%)
Intraoperative data
RACHS-1c (11)
1 13 (4%) 0 0
2 56 (18%) 21 (13%) 10 (11%)
3 113 (37%) 55 (34%) 26 (29%)
4 54 (18%) 36 (22%) 26 (29%)
6 72 (23%) 49 (30%) 27 (30%)
Intraoperative minutes 297.7 ± 74.6 340.5 ± 93.7b 351.2 ± 179.5b
Cardiopulmonary bypass 69.1 ± 49.1 84.2 ± 70.1b 96.8 ± 83.3b
minutes 134 (44%) 79 (49%) 44 (49%)
Circulatory arrest n (%) 16 ± 21.2 16.6 ± 21.1 17 ± 21.4
Circ arrest minutes 9 (3%) 22 (15%) [4.4; 2, 9.4]b 15 (18%) [4.1; 2, 8.6]b
Multiple cross-clamp 213 (70%) 132 (82%) [1.9; 1.2, 3]b 70 (80%)
Modified ultra filtration 164.1 ± 150.9 250.6 ± 190.8b 262.5 ± 221.9b
Ultrafiltrate (mlÆkg)1) 103.2 ± 73.1 105.8; 86.9 ± 58.8 86.9 ± 50.1
Furosemide 35 (11%) 23 (14%) 20 (23%) [2.3; 1.3, 4.2]b
Gentamicin or vancomycin 16 (5%) 6 (4%) 3 (3%)
Aprotinin 248 (81%) 134 (83%) 76 (85%)
Inotropic support 280 (91%) 146 (97%) [3.1; 1.2, 8.1]b 86 (97%)
Dopamine 277 (90%) 148 (92%) 78 (88%)
Milrinone 97 (32%) 87 (54%) [2.4; 1.6, 3.5]b 49 (55%) [2.1; 1.3, 3.3]b
Epinephrine 153 (50%) 116 (72%) [2.4; 1.6, 3.6]b 71 (80%) [3.4; 2, 6]b
Transfusion required 182 (59%) 116 (72%) [1.7; 1.2, 2.6]b 64 (72%) [1.6; 0.96–2.6]b
PRBC transfused 78 (25%) 64 (40%) [2.0; 1.3, 3]b 38 (43%) [2.0; 1.3, 3.2]b
Platelets or FFP 156 (51%) 108 (67%) [1.9; 1.3, 2.9]b 59 (66%) [1.6; 1, 2.7]b
Hematocrit end of case 38.2 ± 7.7b 40.8 ± 7.7b 40.9 ± 7.7b
Albumin administered 167 (54%) 100 (62%) 57 (64%)
Data presented as mean ± SD or n (%) [odds ratio; confidence interval], where applicable.
a72 children in the AKI-RI group also developed kidney failure.
bP < 0.05 vs other children.
cRACHS-1 scored as previously described as follows: (1) atrial septal defects, coarctation repair, etc.; (2) hemifontan, ventriculo-septal
defects; (3) arterial switch, Fontan, mitral valve procedures; (4) aortic arch or truncus procedures, combinations; (6) Norwood.
PRBC, packed red blood cells, FFP, fresh frozen plasma; AKI-RI, acute kidney risk or injury; ECMO, extracorporeal membrane oxygenation;
RACHS-1, risk assessment in congenital heart surgery criteria.
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Several factors, including young age, small size, and
cyanosis have been previously associated with renal
failure following CPB in children (4,6,16). Inconsisten-
cies in findings, however, suggest that mediation of
these inherent risk factors by multiple perioperative
factors, including use of inotropes and other agents,
acute inflammation, and poor cardiac function affect
renal outcomes in this population (9,17). Data from
the present study support a multifactorial relationship
between the perioperative course and renal outcomes,
with many such factors indicative of low cardiac out-
put states during this period. In fact, children who
received preoperative dobutamine and/or milrinone,
and intraoperative epinephrine were nearly three times
as likely to develop AKI-RI or kidney failure post-
operatively. Furthermore, cardiac failure, sepsis, need
for ECMO and open chest postoperatively were signifi-
cantly associated with AKI-RI and failure. Hoffman,
et al. (18) previously reported that children without
preoperative low cardiac output syndrome (LCOS)
randomized to receive milrinone immediately after sur-
gery were less likely to develop LCOS and had no dif-
ference in creatinine clearance compared to those who
received placebo. In contrast, children in the present
study setting received milrinone or other inotropes for
treatment of LCOS. It may therefore be likely that
underlying cardiac failure is the primary factor leading
to poor renal outcomes, with inotropes as secondary
indicators.
We further found that children with poor renal out-
comes were 4–12 times more likely to have received
diuretics, gentamicin, and mechanical ventilation pre-
operatively. Intravenous diuretics are used in our set-
ting to treat oliguria associated with congestive failure,
and gentamicin was used to treat fever during septic
work-ups. These variables therefore indicate underlying
physiologic compromise that may place children at
higher risk. Simsic et al. (19) reported that newborns
who were mechanically ventilated preoperatively had a
greater degree of preoperative hemodynamic compro-
mise and higher inotropic scores compared to sponta-
neously breathing neonates. These risk factors are
therefore likely interdependent.
In this sample, children with AKI-RI or failure were
equally likely to have received aprotinin compared to
controls. Early randomized, controlled trials of aproti-
nin in children and adults reported no differences in
renal outcomes between those who received the agent
vs placebo (20,21). In contrast, two retrospective stud-
ies in large samples of adults who underwent coronary








Respiratory 37 (12%) 43 (27%) [2.4; 1.5, 3.9] 24 (27%) [2; 1.2, 3.5]
Neurologic 15 (5%) 29 (18%) [3.8; 2, 7] 23 (26%) [5.6; 3, 10.5]
Sepsis 21 (7%) 40 (25%) [3.2; 1.9, 5.3] 35 (41%) [6.9; 4, 11.9]
Cardiovascular 102 (33%) 117 (73%) [4.8; 3.1, 7.2] 82 (93%) [21.7; 9.2, 50.9]
ECMO 5 (2%) 50 (31%) [8.7; 4.8, 16] 52 (59%) [39.4; 19.9, 77.9]
Low-output cardiac failure 20 (7%) 57 (36%) [5.6; 3.4, 9.3] 51 (58%) [14.2; 8.2, 24.6]
Chest open after surgery 100 (33%) 83 (52%) [2; 1.4, 3] 59 (67%) [3.8; 2.4, 6.3]
Additional surgery required 25 (8%) 56 (35%) [4.6; 2.8, 7.4] 46 (52%) [8.8; 5.2, 14.8]
Death 18 (6%) 68 (42%) [6.7; 4.1, 10.8] 68 (76%) [36.9; 20, 67.9]
Data presented as n (%) [odds ratio; confidence interval].
*All comparisons were significant between group vs other children (P < 0.017).
AKI-RI, acute kidney risk or injury; ECMO, extracorporeal membrane oxygenation.
Table 2 Perioperative factors independently associated with acute
kidney injury and failure (results of multivariate analysis)
AKI-RI Failure
Age 9.26; 0.002 NS
Gentamicin preoperative NS 10.6; 0.001
[3 (1.6, 5.7)]





4.3; 0.038 3.8; 0.051
[1.8 (1, 3.3)]
Dobutamine preoperative NS 3.9; 0.047
Multiple cross-clamp 7.9; 0.005
[2.8 (1.2, 6.3)]
NS
CPB duration NS 10.5; 0.001
Ultrafiltrate removed NS 4.8; 0.028
Anesthesia duration 12.6; <0.001 NS
Data presented as Wald statistic; P value with [Exp B (Confidence
interval)], as appropriate. NS, Not significant; CPB, cardiopulmonary
bypass.
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artery bypass surgery found an increased risk of renal
injury, myocardial infarction, and death in patients
who received aprotinin (22,23). These studies led to the
withdrawal of the agent from the US market. More
recently, two retrospective, case–control studies in chil-
dren reported no association between the use of aproti-
nin and renal failure in children (14,15). Szekely et al.
(24) similarly found that while children who received
aprotinin had higher rates of renal dysfunction and
failure, when risk adjusted using propensity matching,
the independent role of aprotinin in the development
of poor renal outcomes was not supported. While tran-
sient effects of aprotinin on renal function have been
described, the effects on renal function in children
remain poorly understood. Further study using a ran-
domized, controlled design in large samples of children
is warranted to better evaluate safety in this popula-
tion.
Several aspects of CPB and surgery, however, have
been implicated as risk factors for poor renal outcomes
(17). The present study found that prolonged surgery
and CPB duration, and multiple cross-clamp during
surgery were associated with adverse renal outcomes, a
finding similar to earlier studies (5,6). Duration of sur-
gery, bypass, and cross-clamp likely reflects the com-
plexity of the defect and surgical repair. The
underlying lesions in these cases, as well as nonpulsa-
tile flow during CPB, may be associated with decreased
perfusion states, placing the kidneys at greater risk. In
contrast to earlier data (5,6), the use of DHCA was
not associated with AKI-RI in the present study.
Advances in surgical techniques including completing
as much dissection as possible prior to initiation of
DHCA have shortened the duration of arrest, thereby
reducing the associated risks of circulatory arrest over
time. Lastly, the global inflammatory response that
correlates with CPB duration (17,25), and to which
younger and smaller patients are more susceptible (26),
may further contribute to poor renal outcomes. Several
techniques commonly used during CPB, including
MUF, hemofiltration or use of aprotinin, attenuate the
inflammatory response (26). The reduction in inflam-
matory mediators is transient, and its relationship with
postoperative outcomes is unclear. MUF has been
shown, however, to decrease the duration of postoper-
ative mechanical ventilation, and improve hemodynam-
ic parameters (26), suggesting improved end-organ
perfusion. In the present study, the relationship
between the use of these techniques and adverse renal
outcomes was not found.
Previous investigators have found a significant asso-
ciation between the lowest hematocrit during CPB and
postoperative renal injury in adults (27). Furthermore,
these effects on renal injury were worsened if early
PRBC transfusions were utilized to correct the low
hematocrit (27). While we were unable to demonstrate
a similar association between hematocrit and renal
injury, we found that transfusion of blood products
was significantly associated with but was not an inde-
pendent predictor of AKI-RI or failure. The relation-
ship between a low hematocrit, transfusion of blood
products and renal risk requires further investigation
in children undergoing CPB.
The ability to generalize findings from this study
may be limited by several methodological issues com-
mon to retrospective designs. Firstly, cases were identi-
fied from the nephrology consult database, and it
remains unknown whether all cases of AKI-RI or fail-
ure were included. Also, it remains possible that
observed associations are because of the effect of some
confounding variable, such as serum glucose levels and
other factors, not included in these analyses. In an
attempt to identify such confounders, correlations and
univariate analyses were initially performed including
all patient-related and perioperative factors collected
for this study. Lastly, it is well known that there may
be significant variability in practices across settings,
which limits the ability to generalize findings.
Conclusion
Although this study cannot draw cause and effect rela-
tionships, the findings have identified multiple peri-
operative factors associated with the development of
untoward renal outcomes. Young age, multiple cross-
clamps and longer intraoperative times were found to
be associated with both AKI-RI and failure. The use
of milrinone preoperatively and intraoperatively was
associated with AKI-RI but not kidney failure, while
preoperative ventilation and gentamicin and intraoper-
ative furosemide were associated with kidney failure
but not AKI-RI. These findings suggest a complex
interrelationship between perioperative factors and
poor renal outcomes in children who undergo CPB.
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